Back


16/11/2017
Kurma Partners announces the successful IPO of Orphazyme.
Kurma Partners announces the successful IPO of Orphazyme, a leading company in rare diseases which raises €80M on Nasdaq Copenhagen [....]

Download the pdf file





X

X